Maps and legends: The quest for dissociated ligands of the glucocorticoid receptor

Pharmacology and Therapeutics

Volumn 134, Issue 1, 2012, Pages 54-67

  Clark, Andrew R ^a   Belvisi, Maria G ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Glucocorticoid; Inflammation; Metabolism; Selective glucocorticoid receptor modulators; Transcription; Transrepression

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CATARACT; DIABETES MELLITUS; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; GENE EXPRESSION REGULATION; GIANT CELL ARTERITIS; GLAUCOMA; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERTENSION; HYPOTHESIS; IMMUNOMODULATION; INFECTION; INFLAMMATORY DISEASE; MOOD DISORDER; MUSCLE ATROPHY; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SKIN ATROPHY; SKIN INFLAMMATION; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION; TRANSREPRESSION HYPOTHESIS; WOUND HEALING IMPAIRMENT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; GLUCOCORTICOIDS; HUMANS; LIGANDS; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION, GENETIC;

EID: 84857362332     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.12.004     Document Type: Review

References (179)

1. M.M. Aagaard, R. Siersbaek, and S. Mandrup Molecular basis for gene-specific transactivation by nuclear receptors Biochim Biophys Acta 1812 2011 824 835
2. S.M. Abraham, T. Lawrence, A. Kleiman, P. Warden, M. Medghalchi, J. Tuckermann, J. Saklatvala, and A.R. Clark Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 J Exp Med 203 2006 1883 1889
3. N. Auphan, J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis Science 270 1995 286 290
4. C. Avenant, A. Kotitschke, and J.P. Hapgood Glucocorticoid receptor phosphorylation modulates transcription efficacy through GRIP-1 recruitment Biochemistry 49 2010 972 985
5. P.J. Barnes Anti-inflammatory mechanisms of glucocorticoids Biochem Soc Trans 23 1995 940 945
6. P.J. Barnes Corticosteroids: the drugs to beat Eur J Pharmacol 533 2006 2 14
7. U. Baschant, L. Frappart, U Rauchhaus, L. Bruns, H.M. Reichardt, T. Kamradt, R. Brauer, and J.P. Tuckermann Glucocorticoid therapy of arthritis depends on the dimerized glucocorticoid receptor in T cells Proc Natl Acad Sci U S A 108 2011 19317 19322
8. E. Beaulieu, and E.F. Morand Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis Nat Rev Rheumatol 7 2011 340 348
9. E. Beaulieu, D. Ngo, L. Santos, Y.H. Yang, M. Smith, C. Jorgensen, V. Escriou, D. Scherman, G. Courties, F. Apparailly, and E.F. Morand Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis Arthritis Rheum 62 2010 2651 2661
10. S.A. Beausoleil, J. Villen, S.A. Gerber, J. Rush, and S.P. Gygi A probability-based approach for high-throughput protein phosphorylation analysis and site localization Nat Biotechnol 24 2006 1285 1292
11. I.M. Beck, W. Vanden Berghe, L. Vermeulen, K.R. Yamamoto, G. Haegeman, and K. De Bosscher Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases Endocr Rev 30 2009 830 882
12. M.G. Belvisi, S.L. Wicks, C.H. Battram, S.E. Bottoms, J.E. Redford, P. Woodman, T.J. Brown, S.E. Webber, and M.L. Foster Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity J Immunol 166 2001 1975 1982
13. M.W. Bergmann, K.J. Staples, S.J. Smith, P.J. Barnes, and R. Newton Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-kappaB and conserved lymphokine element 0 Am J Respir Cell Mol Biol 30 2004 555 563
14. M. Berlin Recent advances in the development of novel glucocorticoid receptor modulators Expert Opin Ther Pat 20 2010 855 873
15. R. Bhandare, G. Damera, A. Banerjee, J.R. Flammer, S. Keslacy, I. Rogatsky, R.A. Panettieri, Y. Amrani, and O. Tliba Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells Am J Respir Cell Mol Biol 42 2010 9 15
16. S.C. Biddie, S. John, and G.L. Hager Genome-wide mechanisms of nuclear receptor action Trends Endocrinol Metab 21 2010 3 9
17. S.C. Biddie, S. John, P.J. Sabo, R.E. Thurman, T.A. Johnson, R.L. Schiltz, T.B. Miranda, M.H. Sung, S. Trump, S.L. Lightman, C. Vinson, J.A. Stamatoyannopoulos, and G.L. Hager Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding Mol Cell 43 2011 145 155
18. S. Bilodeau, S. Vallette-Kasic, Y. Gauthier, D. Figarella-Branger, T. Brue, F. Berthelet, A. Lacroix, D. Batista, C. Stratakis, J. Hanson, B. Meij, and J. Drouin Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease Genes Dev 20 2006 2871 2886
19. L.G. Bladh, K. Johansson-Haque, I. Rafter, S. Nilsson, and S. Okret Inhibition of extracellular signal-regulated kinase (ERK) signaling participates in repression of nuclear factor (NF)-kappaB activity by glucocorticoids Biochim Biophys Acta 1793 2009 439 446
20. R.K. Bledsoe, V.G. Montana, T.B. Stanley, C.J. Delves, C.J. Apolito, D.D. McKee, T.G. Consler, D.J. Parks, E.L. Stewart, T.M. Willson, M.H. Lambert, J.T. Moore, K.H. Pearce, and H.E. Xu Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition Cell 110 2002 93 105
21. F. Boldizsar, G. Talaber, M. Szabo, D. Bartis, L. Palinkas, P. Nemeth, and T. Berki Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells Immunobiology 215 2010 521 526
22. J.C. Buckingham Glucocorticoids: exemplars of multi-tasking Br J Pharmacol 147 Suppl. 1 2006 S258 S268
23. E. Caldenhoven, J. Liden, S. Wissink, A. Van de Stolpe, J. Raaijmakers, L. Koenderman, S. Okret, J.A. Gustafsson, and P.T. Van der Saag Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids Mol Endocrinol 9 1995 401 412
24. A.C. Cato, and E. Wade Molecular mechanisms of anti-inflammatory action of glucocorticoids Bioessays 18 1996 371 378
25. M.M. Chang, M. Juarez, D.M. Hyde, and R. Wu Mechanism of dexamethasone-mediated interleukin-8 gene suppression in cultured airway epithelial cells Am J Physiol Lung Cell Mol Physiol 280 2001 L107 L115
26. L.R. Chaudhary, and L.V. Avioli Regulation of interleukin-8 gene expression by interleukin-1beta, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells J Biol Chem 271 1996 16591 16596
27. W. Chen, T. Dang, R.D. Blind, Z. Wang, C.N. Cavasotto, A.B. Hittelman, I. Rogatsky, S.K. Logan, and M.J. Garabedian Glucocorticoid receptor phosphorylation differentially affects target gene expression Mol Endocrinol 22 2008 1754 1766
28. W. Chen, I. Rogatsky, and M.J. Garabedian MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor Mol Endocrinol 20 2006 560 572
29. Y. Chinenov, and I. Rogatsky Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network Mol Cell Endocrinol 275 2007 30 42
30. Y. Chinenov, M.A. Sacta, A.R. Cruz, and I. Rogatsky GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression Proc Natl Acad Sci U S A 105 2008 20185 20190
31. J.E. Chivers, W. Gong, E.M. King, J. Seybold, J.C. Mak, L.E. Donnelly, N.S. Holden, and R. Newton Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids Mol Pharmacol 70 2006 2084 2095
32. I.J. Cho, and S.G. Kim A novel mitogen-activated protein kinase phosphatase-1 and glucocorticoid receptor (GR) interacting protein-1-dependent combinatorial mechanism of gene transrepression by GR Mol Endocrinol 23 2009 86 99
33. S. Chung, G.H. Son, and K. Kim Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications Biochim Biophys Acta 1812 2011 581 591
34. A.R. Clark Anti-inflammatory functions of glucocorticoid-induced genes Mol Cell Endocrinol 275 2007 79 97
35. B.A. Clarke, D. Drujan, M.S. Willis, L.O. Murphy, R.A. Corpina, E. Burova, S.V. Rakhilin, T.N. Stitt, C. Patterson, E. Latres, and D.J. Glass The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle Cell Metab 6 2007 376 385
36. T.J. Cole, J.A. Blendy, A.P. Monaghan, K. Krieglstein, W. Schmid, A. Aguzzi, G. Fantuzzi, E. Hummler, K. Unsicker, and G. Schutz Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation Genes Dev 9 1995 1608 1621
37. M.M. Conradie, A.C. Cato, W.F. Ferris, H. de Wet, K. Horsch, and S. Hough MKP-1 knockout does not prevent glucocorticoid-induced bone disease in mice Calcif Tissue Int 89 2011 221 227
38. M.M. Conradie, H. de Wet, D.D. Kotze, J.M. Burrin, F.S. Hough, and P.A. Hulley Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo J Endocrinol 195 2007 229 240
39. A.E. Coutinho, and K.E. Chapman The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights Mol Cell Endocrinol 335 2011 2 13
40. K. Dahlman-Wright, K. Grandien, S. Nilsson, J.A. Gustafsson, and J. Carlstedt-Duke Protein-protein interactions between the DNA-binding domains of nuclear receptors: influence on DNA-binding J Steroid Biochem Mol Biol 45 1993 239 250
41. K. Dahlman-Wright, A.P. Wright, and J.A. Gustafsson Determinants of high-affinity DNA binding by the glucocorticoid receptor: evaluation of receptor domains outside the DNA-binding domain Biochemistry 31 1992 9040 9044
42. K. Dahlman-Wright, A. Wright, J.A. Gustafsson, and J. Carlstedt-Duke Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids J Biol Chem 266 1991 3107 3112
43. H. Daub, J.V. Olsen, M. Bairlein, F. Gnad, F.S. Oppermann, R. Korner, Z. Greff, G. Keri, O. Stemmann, and M. Mann Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle Mol Cell 31 2008 438 448
44. K. De Bosscher, G. Haegeman, and D. Elewaut Targeting inflammation using selective glucocorticoid receptor modulators Curr Opin Pharmacol 10 2010 497 504
45. K. De Bosscher, W. Vanden Berghe, I.M. Beck, W. Van Molle, N. Hennuyer, J. Hapgood, C. Libert, B. Staels, A. Louw, and G. Haegeman A fully dissociated compound of plant origin for inflammatory gene repression Proc Natl Acad Sci U S A 102 2005 15827 15832
46. N. Dephoure, C. Zhou, J. Villen, S.A. Beausoleil, C.E. Bakalarski, S.J. Elledge, and S.P. Gygi A quantitative atlas of mitotic phosphorylation Proc Natl Acad Sci U S A 105 2008 10762 10767
47. L. Dhawan, B. Liu, B.C. Blaxall, and M.B. Taubman A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability J Biol Chem 282 2007 10146 10152
48. T. Dickmeis, and N.S. Foulkes Glucocorticoids and circadian clock control of cell proliferation: at the interface between three dynamic systems Mol Cell Endocrinol 331 2011 11 22
49. M. Diefenbacher, S. Sekula, C. Heilbock, J.V. Maier, M. Litfin, H. van Dam, M. Castellazzi, P. Herrlich, and O. Kassel Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1 Mol Endocrinol 22 2008 1767 1780
50. A. Dostert, and T. Heinzel Negative glucocorticoid receptor response elements and their role in glucocorticoid action Curr Pharm Des 10 2004 2807 2816
51. N. Draper, and P.M. Stewart 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action J Endocrinol 186 2005 251 271
52. W. Eberhardt, T. Kilz, S. Akool el, R. Muller, and J. Pfeilschifter Dissociated glucocorticoids equipotently inhibit cytokine- and cAMP-induced matrix degrading proteases in rat mesangial cells Biochem Pharmacol 70 2005 433 445
53. S. Essilfie-Quaye, K. Ito, M. Ito, S.A. Kharitonov, and P.J. Barnes Comparison of symbicort versus pulmicort on steroid pharmacodynamic markers in asthma patients Respir Med 105 2011 1784 1789
54. L. Fardet, I. Petersen, and I. Nazareth Prevalence of long-term oral glucocorticoid prescriptions in UK over the past 20 years Rheumatology (Oxford) 50 2011 1982 1990
55. J.R. Flammer, J. Dobrovolna, M.A. Kennedy, Y. Chinenov, C.K. Glass, L.B. Ivashkiv, and I. Rogatsky The type I interferon signaling pathway is a target for glucocorticoid inhibition Mol Cell Biol 30 2010 4564 4574
56. J.R. Flammer, and I. Rogatsky Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms Mol Endocrinol 25 2011 1075 1086
57. R. Frijters, W. Fleuren, E.J. Toonen, J.P. Tuckermann, H.M. Reichardt, H. Van der Maaden, A. Van Elsas, M.J. Van Lierop, W. Dokter, J. De Vlieg, and W. Alkema Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor BMC Genomics 11 2010 359
58. R. Furst, T. Schroeder, H.M. Eilken, M.F. Bubik, A.K. Kiemer, S. Zahler, and A.M. Vollmar MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium FASEB J 21 2007 74 80
59. A.J. Galliher-Beckley, and J.A. Cidlowski Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease IUBMB Life 61 2009 979 986
60. A.J. Galliher-Beckley, J.G. Williams, J.B. Collins, and J.A. Cidlowski Glycogen synthase kinase 3{beta}-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles Mol Cell Biol 28 2008 7309 7322
61. C. Geserick, H.A. Meyer, and B. Haendler The role of DNA response elements as allosteric modulators of steroid receptor function Mol Cell Endocrinol 236 2005 1 7
62. H. Gilson, O. Schakman, L. Combaret, P. Lause, L. Grobet, D. Attaix, J.M. Ketelslegers, and J.P. Thissen Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy Endocrinology 148 2007 452 460
63. C.K. Glass, and K. Saijo Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells Nat Rev Immunol 10 2010 365 376
64. S.L. Gorter, J.W. Bijlsma, M. Cutolo, J. Gomez-Reino, M. Kouloumas, J.S. Smolen, and R. Landewe Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis Ann Rheum Dis 69 2010 1010 1014
65. V. Gossye, D. Elewaut, N. Bougarne, D. Bracke, S. Van Calenbergh, G. Haegeman, and K. De Bosscher Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts Arthritis Rheum 60 2009 3241 3250
66. I. Grad, and D. Picard The glucocorticoid responses are shaped by molecular chaperones Mol Cell Endocrinol 275 2007 2 12
67. F.L. Groeneweg, H. Karst, E.R. de Kloet, and M. Joels Rapid non-genomic effects of corticosteroids and their role in the central stress response J Endocrinol 209 2011 153 167
68. H. Gronemeyer, and W. Bourguet Allosteric effects govern nuclear receptor action: DNA appears as a player Sci Signal 2 2009 pe34
69. Haendler, B., & Cleve, A. in press. Recent developments in antiandrogens and selective androgen receptor modulators. Mol Cell Endocrinol.
70. O. Hakim, S. John, J.Q. Ling, S.C. Biddie, A.R. Hoffman, and G.L. Hager Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions J Biol Chem 284 2009 6048 6052
71. S.J. Han, D.M. Lonard, and B.W. O'Malley Multi-modulation of nuclear receptor coactivators through posttranslational modifications Trends Endocrinol Metab 20 2009 8 15
72. D.C. Hargreaves, T. Horng, and R. Medzhitov Control of inducible gene expression by signal-dependent transcriptional elongation Cell 138 2009 129 145
73. S. Heck, K. Bender, M. Kullmann, M. Gottlicher, P. Herrlich, and A.C. Cato I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor EMBO J 16 1997 4698 4707
74. S. Heck, M. Kullmann, A. Gast, H. Ponta, H.J. Rahmsdorf, P. Herrlich, and A.C. Cato A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1 EMBO J 13 1994 4087 4095
75. P.S. Hench Nobel Lectures, Physiology or Medicine, 1942-1962 1964 Elsevier Publishing Company Amsterdam 312 341
76. S.G. Hillier Diamonds are forever: the cortisone legacy J Endocrinol 195 2007 1 6
77. J.N. Hoes, J.W. Jacobs, F. Buttgereit, and J.W. Bijlsma Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis Nat Rev Rheumatol 6 2010 693 702
78. L.C. Hofbauer, and M. Rauner Minireview: live and let die: molecular effects of glucocorticoids on bone cells Mol Endocrinol 23 2009 1525 1531
79. K. Horsch, H. de Wet, M.M. Schuurmans, F. Allie-Reid, A.C. Cato, J. Cunningham, J.M. Burrin, F.S. Hough, and P.A. Hulley Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation Mol Endocrinol 21 2007 2929 2940
80. A.R. Hudson, S.L. Roach, and R.I. Higuchi Recent developments in the discovery of selective glucocorticoid receptor modulators (SGRMs) Curr Top Med Chem 8 2008 750 765
81. F.T. Ishmael, X. Fang, M.R. Galdiero, U. Atasoy, W.F. Rigby, M. Gorospe, C. Cheadle, and C. Stellato Role of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation J Immunol 180 2008 8342 8353
82. F.T. Ishmael, X. Fang, K.R. Houser, K. Pearce, K. Abdelmohsen, M. Zhan, M. Gorospe, and C. Stellato The human glucocorticoid receptor as an RNA-binding protein: global analysis of glucocorticoid receptor-associated transcripts and identification of a target RNA motif J Immunol 186 2011 1189 1198
83. K.N. Islam, and C.R. Mendelson Glucocorticoid/glucocorticoid receptor inhibition of surfactant protein-A (SP-A) gene expression in lung type II cells is mediated by repressive changes in histone modification at the SP-A promoter Mol Endocrinol 22 2008 585 596
84. N. Ismaili, R. Blind, and M.J. Garabedian Stabilization of the unliganded glucocorticoid receptor by TSG101 J Biol Chem 280 2005 11120 11126
85. K. Ito, P.J. Barnes, and I.M. Adcock Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12 Mol Cell Biol 20 2000 6891 6903
86. M. Janka-Junttila, E. Moilanen, H. Hasala, X. Zhang, I. Adcock, and H. Kankaanranta The glucocorticoid RU24858 does not distinguish between transrepression and transactivation in primary human eosinophils J Inflamm (Lond) 3 2006 10
87. E. Joanny, Q. Ding, L. Gong, P. Kong, J. Saklatvala, and A.R. Clark Anti-inflammatory effects of selective glucocorticoid receptor modulators (SGRMs) are partially dependent on upregulation of dual specificity phosphatase 1 (DUSP1) Br J Pharmacol 65 2012 1124 1136
88. S. John, P.J. Sabo, T.A. Johnson, M.H. Sung, S.C. Biddie, S.L. Lightman, T.C. Voss, S.R. Davis, P.S. Meltzer, J.A. Stamatoyannopoulos, and G.L. Hager Interaction of the glucocorticoid receptor with the chromatin landscape Mol Cell 29 2008 611 624
89. S. John, P.J. Sabo, R.E. Thurman, M.H. Sung, S.C. Biddie, T.A. Johnson, G.L. Hager, and J.A. Stamatoyannopoulos Chromatin accessibility pre-determines glucocorticoid receptor binding patterns Nat Genet 43 2011 264 268
90. J.O. Jones Improving selective androgen receptor modulator discovery and preclinical evaluation Curr Opin Drug Discov 4 2009 981 993
91. B.N. Kang, J.A. Jude, R.A. Panettieri Jr., T.F. Walseth, and M.S. Kannan Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: role of dual specificity phosphatase 1 Am J Physiol Lung Cell Mol Physiol 295 2008 L186 L193
92. J.A. Kanis, M. Stevenson, E.V. McCloskey, S. Davis, and M. Lloyd-Jones Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis Health Technol Assess 11 2007 iii iv ix-xi, 1-231
93. Kelly, M., King, E., Rider, C., Gwozd, C., Holden, N., Eddleston, J., Zuraw, B., Leigh, R., O'Byrne, P., & Newton, R. (in press) Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide. Br J Pharmacol, doi: 10.1111/j.1476-5381.2011.01620. x.
94. E.M. King, N.S. Holden, W. Gong, C.F. Rider, and R. Newton Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK J Biol Chem 284 2009 26803 26815
95. T. Kino, and G.P. Chrousos Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids: implications for cardiometabolic diseases Endocr Dev 20 2011 116 126
96. J.R. Kirwan, J.W. Bijlsma, M. Boers, and B.J. Shea Effects of glucocorticoids on radiological progression in rheumatoid arthritis Cochrane Database Syst Rev 2007 CD006356. PMID: 17253590
97. A. Kleiman, and J.P. Tuckermann Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice Mol Cell Endocrinol 275 2007 98 108
98. Kleiman, A., Hubner, S., Rodriguez Parkitna, J. M., Neumann, A., Hofer, S., Weigand, M. A., Bauer, M., Schmid, W., Schutz, G., Libert, C., Reichardt, H. M., & Tuckermann, J. P. (in press). Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J.
99. J.A. Lefstin, J.R. Thomas, and K.R. Yamamoto Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions Genes Dev 8 1994 2842 2856
100. D.C. Leitman, S. Paruthiyil, O.I. Vivar, E.F. Saunier, C.B. Herber, I. Cohen, M. Tagliaferri, and T.P. Speed Regulation of specific target genes and biological responses by estrogen receptor subtype agonists Curr Opin Pharmacol 10 2010 629 636
101. F. Li, M. Zhang, F. Hussain, K. Triantaphyllopoulos, A.R. Clark, P.K. Bhavsar, X. Zhou, and K.F. Chung Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids Eur Respir J 37 2011 933 942
102. J. Liden, F. Delaunay, I. Rafter, J. Gustafsson, and S. Okret A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation J Biol Chem 272 1997 21467 21472
103. F.J. Lopez, R.J. Ardecky, B. Bebo, K. Benbatoul, L. De Grandpre, S. Liu, M.D. Leibowitz, K. Marschke, J. Rosen, D. Rungta, H.O. Viveros, W.C. Yen, L. Zhi, A. Negro-Vilar, and J.N. Miner LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo Endocrinology 149 2008 2080 2089
104. H.F. Luecke, and K.R. Yamamoto The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression Genes Dev 19 2005 1116 1127
105. W. Ma, K. Gee, W. Lim, K. Chambers, J.B. Angel, M. Kozlowski, and A. Kumar Dexamethasone inhibits IL-12p40 production in lipopolysaccharide- stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors J Immunol 172 2004 318 330
106. A. Malovannaya, R.B. Lanz, S.Y. Jung, Y. Bulynko, N.T. Le, D.W. Chan, C. Ding, Y. Shi, N. Yucer, G. Krenciute, B.J. Kim, C. Li, R. Chen, W. Li, Y. Wang, B.W. O'Malley, and J. Qin Analysis of the human endogenous coregulator complexome Cell 145 2011 787 799
107. J.H. Martens, N.A. Rao, and H.G. Stunnenberg Genome-wide interplay of nuclear receptors with the epigenome Biochim Biophys Acta 1812 2011 818 823
108. D.P. McDonnell, and S.E. Wardell The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer Curr Opin Pharmacol 10 2010 620 628
109. I.J. McEwan, A.P. Wright, and J.A. Gustafsson Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions Bioessays 19 1997 153 160
110. N.J. McKenna, A.J. Cooney, F.J. DeMayo, M. Downes, C.K. Glass, R.B. Lanz, M.A. Lazar, D.J. Mangelsdorf, D.D. Moore, J. Qin, D.L. Steffen, M.J. Tsai, S.Y. Tsai, R. Yu, R.N. Margolis, R.M. Evans, and B.W. O'Malley Minireview: evolution of NURSA, the Nuclear Receptor Signaling Atlas Mol Endocrinol 23 2009 740 746
111. A. McMaster, and D.W. Ray Drug insight: selective agonists and antagonists of the glucocorticoid receptor Nat Clin Pract Endocrinol Metab 4 2008 91 101
112. S.H. Meijsing, M.A. Pufall, A.Y. So, D.L. Bates, L. Chen, and K.R. Yamamoto DNA binding site sequence directs glucocorticoid receptor structure and activity Science 324 2009 407 410
113. J.N. Miner, B. Ardecky, K. Benbatoul, K. Griffiths, C.J. Larson, D.E. Mais, K. Marschke, J. Rosen, E. Vajda, L. Zhi, and A. Negro-Vilar Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile Proc Natl Acad Sci U S A 104 2007 19244 19249
114. J.N. Miner, M.H. Hong, and A. Negro-Vilar New and improved glucocorticoid receptor ligands Expert Opin Investig Drugs 14 2005 1527 1545
115. N. Mukaida, M. Morita, Y. Ishikawa, N. Rice, S. Okamoto, T. Kasahara, and K. Matsushima Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression J Biol Chem 269 1994 13289 13295
116. N. Nader, G.P. Chrousos, and T. Kino Interactions of the circadian CLOCK system and the HPA axis Trends Endocrinol Metab 21 2010 277 286
117. R. Newton Molecular mechanisms of glucocorticoid action: what is important? Thorax 55 2000 603 613
118. R. Newton, and N.S. Holden Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol Pharmacol 72 2007 799 809
119. R. Newton, E.M. King, W. Gong, C.F. Rider, K.J. Staples, N.S. Holden, and M.W. Bergmann Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1 Biochem J 427 2010 113 124
120. R. Newton, J. Seybold, L.M. Kuitert, M. Bergmann, and P.J. Barnes Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA J Biol Chem 273 1998 32312 32321
121. M. Nie, A.J. Knox, and L. Pang Beta2-adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation J Immunol 175 2005 478 486
122. S. Nilsson, and J.A. Gustafsson Estrogen receptors: therapies targeted to receptor subtypes Clin Pharmacol Ther 89 2011 44 55
123. R.M. Nissen, and K.R. Yamamoto The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain Genes Dev 14 2000 2314 2329
124. R.H. Oakley, and J.A. Cidlowski Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids J Biol Chem 286 2011 3177 3184
125. S. Ogawa, J. Lozach, C. Benner, G. Pascual, R.K. Tangirala, S. Westin, A. Hoffmann, S. Subramaniam, M. David, M.G. Rosenfeld, and C.K. Glass Molecular determinants of crosstalk between nuclear receptors and toll-like receptors Cell 122 2005 707 721
126. B.W. O'Malley, and N.J. McKenna Coactivators and corepressors: what's in a name? Mol Endocrinol 22 2008 2213 2214
127. Y. Qiu, D.A. Stavreva, Y. Luo, A. Indrawan, M. Chang, and G.L. Hager Dynamic interaction of HDAC1 with a glucocorticoid receptor-regulated gene is modulated by the activity state of the promoter J Biol Chem 286 2011 7641 7647
128. T. Quante, Y.C. Ng, E.E. Ramsay, S. Henness, J.C. Allen, J. Parmentier, Q. Ge, and A.J. Ammit Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1 Am J Respir Cell Mol Biol 39 2008 208 217
129. N.A. Rao, M.T. McCalman, P. Moulos, K.J. Francoijs, A. Chatziioannou, F.N. Kolisis, M.N. Alexis, D.J. Mitsiou, and H.G. Stunnenberg Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes Genome Res 21 2011 1404 1416
130. A. Rauch, V. Gossye, D. Bracke, E. Gevaert, P. Jacques, K. Van Beneden, B. Vandooren, M. Rauner, L.C. Hofbauer, G. Haegeman, D. Elewaut, J.P. Tuckermann, and K. De Bosscher An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation FASEB J 25 2011 1323 1332
131. A. Rauch, S. Seitz, U. Baschant, A.F. Schilling, A. Illing, B. Stride, M. Kirilov, V. Mandic, A. Takacz, R. Schmidt-Ullrich, S. Ostermay, T. Schinke, R. Spanbroek, M.M. Zaiss, P.E. Angel, U.H. Lerner, J.P. David, H.M. Reichardt, M. Amling, G. Schutz, and J.P. Tuckermann Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor Cell Metab 11 2010 517 531
132. M. Rauner, C. Goettsch, N. Stein, S. Thiele, M. Bornhaeuser, K. De Bosscher, G. Haegeman, J. Tuckermann, and L.C. Hofbauer Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells Endocrinology 152 2011 103 112
133. T.E. Reddy, F. Pauli, R.O. Sprouse, N.F. Neff, K.M. Newberry, M.J. Garabedian, and R.M. Myers Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation Genome Res 19 2009 2163 2171
134. H.M. Reichardt, K.H. Kaestner, J. Tuckermann, O. Kretz, O. Wessely, R. Bock, P. Gass, W. Schmid, P. Herrlich, P. Angel, and G. Schutz DNA binding of the glucocorticoid receptor is not essential for survival Cell 93 1998 531 541
135. H.M. Reichardt, J.P. Tuckermann, M. Gottlicher, M. Vujic, F. Weih, P. Angel, P. Herrlich, and G. Schutz Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor EMBO J 20 2001 7168 7173
136. M.M. Reily, C. Pantoja, X. Hu, Y. Chinenov, and I. Rogatsky The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression EMBO J 25 2006 108 117
137. S. Robertson, F. Allie-Reid, W. Vanden Berghe, K. Visser, A. Binder, D. Africander, M. Vismer, K. De Bosscher, J. Hapgood, G. Haegeman, and A. Louw Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound A J Biol Chem 285 2010 8061 8075
138. I. Rogatsky, H.F. Luecke, D.C. Leitman, and K.R. Yamamoto Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts Proc Natl Acad Sci U S A 99 2002 16701 16706
139. I. Rogatsky, J.C. Wang, M.K. Derynck, D.F. Nonaka, D.B. Khodabakhsh, C.M. Haqq, B.D. Darimont, M.J. Garabedian, and K.R. Yamamoto Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor Proc Natl Acad Sci U S A 100 2003 13845 13850
140. I. Rogatsky, K.A. Zarember, and K.R. Yamamoto Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones EMBO J 20 2001 6071 6083
141. K. Ronacher, K. Hadley, C. Avenant, E. Stubsrud, S.S. Simons Jr., A. Louw, and J.P. Hapgood Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction Mol Cell Endocrinol 299 2009 219 231
142. B. Sahu, M. Laakso, K. Ovaska, T. Mirtti, J. Lundin, A. Rannikko, A. Sankila, J.P. Turunen, M. Lundin, J. Konsti, T. Vesterinen, S. Nordling, O. Kallioniemi, S. Hautaniemi, and O.A. Janne Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer EMBO J 30 2011 3962 3976
143. G.M. Santos, L. Fairall, and J.W. Schwabe Negative regulation by nuclear receptors: a plethora of mechanisms Trends Endocrinol Metab 22 2011 87 93
144. H. Schacke, M. Berger, H. Rehwinkel, and K. Asadullah Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index Mol Cell Endocrinol 275 2007 109 117
145. H. Schacke, W.D. Docke, and K. Asadullah Mechanisms involved in the side effects of glucocorticoids Pharmacol Ther 96 2002 23 43
146. H. Schacke, H. Rehwinkel, and K. Asadullah Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index Curr Opin Investig Drugs 6 2005 503 507
147. R.I. Scheinman, P.C. Cogswell, A.K. Lofquist, and A.S. Baldwin Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids Science 270 1995 283 286
148. R. Siersbaek, R. Nielsen, S. John, M.H. Sung, S. Baek, A. Loft, G.L. Hager, and S. Mandrup Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis EMBO J 30 2011 1459 1472
149. S.S. Simons Jr. What goes on behind closed doors: physiological versus pharmacological steroid hormone actions Bioessays 30 2008 744 756
150. K. Smoak, and J.A. Cidlowski Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling Mol Cell Biol 26 2006 9126 9135
151. A.Y. So, T.U. Bernal, M.L. Pillsbury, K.R. Yamamoto, and B.J. Feldman Glucocorticoid regulation of the circadian clock modulates glucose homeostasis Proc Natl Acad Sci U S A 106 2009 17582 17587
152. A.Y. So, C. Chaivorapol, E.C. Bolton, H. Li, and K.R. Yamamoto Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor PLoS Genet 3 2007 e94
153. A.Y. So, S.B. Cooper, B.J. Feldman, M. Manuchehri, and K.R. Yamamoto Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes Proc Natl Acad Sci U S A 105 2008 5745 5749
154. K.J. Staples, M.W. Bergmann, P.J. Barnes, and R. Newton Evidence for post-transcriptional regulation of interleukin-5 by dexamethasone Immunology 109 2003 527 535
155. C. Stellato Post-transcriptional and nongenomic effects of glucocorticoids Proc Am Thorac Soc 1 2004 255 263
156. M. Surjit, K.P. Ganti, A. Mukherji, T. Ye, G. Hua, D. Metzger, M. Li, and P. Chambon Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor Cell 145 2011 224 241
157. K. Tanigawa, K. Tanaka, H. Nagase, H. Miyake, M. Kiniwa, and K. Ikizawa Cell type-dependent divergence of transactivation by glucocorticoid receptor ligand Biol Pharm Bull 25 2002 1619 1622
158. M.D. Taves, C.E. Gomez-Sanchez, and K.K. Soma Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function Am J Physiol Endocrinol Metab 301 2011 E11 E24
159. L.G. Tsaprouni, K. Ito, I.M. Adcock, and N. Punchard Suppression of lipopolysaccharide- and tumour necrosis factor-alpha-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation Clin Exp Immunol 150 2007 151 157
160. J.P. Tuckermann, A. Kleiman, R. Moriggl, R. Spanbroek, A. Neumann, A. Illing, B.E. Clausen, B. Stride, I. Forster, A.J. Habenicht, H.M. Reichardt, F. Tronche, W. Schmid, and G. Schutz Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy J Clin Invest 117 2007 1381 1390
161. J.P. Tuckermann, H.M. Reichardt, R. Arribas, K.H. Richter, G. Schutz, and P. Angel The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin J Cell Biol 147 1999 1365 1370
162. S. van der Laan, and O.C. Meijer Pharmacology of glucocorticoids: beyond receptors Eur J Pharmacol 585 2008 483 491
163. G. van Loo, M. Sze, N. Bougarne, J. Praet, C. Mc Guire, A. Ullrich, G. Haegeman, M. Prinz, R. Beyaert, and K. De Bosscher Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis Mol Endocrinol 24 2010 310 322
164. D.H. van Raalte, D.M. Ouwens, and M. Diamant Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest 39 2009 81 93
165. T.P. van Staa, H.G. Leufkens, L. Abenhaim, B. Begaud, B. Zhang, and C. Cooper Use of oral corticosteroids in the United Kingdom QJM 93 2000 105 111
166. B.M. Vayssiere, S. Dupont, A. Choquart, F. Petit, T. Garcia, C. Marchandeau, H. Gronemeyer, and M. Resche-Rigon Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo Mol Endocrinol 11 1997 1245 1255
167. K. Visser, C. Smith, and A. Louw Interplay of the inflammatory and stress systems in a hepatic cell line: interactions between glucocorticoid receptor agonists and interleukin-6 Endocrinology 151 2010 5279 5293
168. D.S. Waddell, L.M. Baehr, J. van den Brandt, S.A. Johnsen, H.M. Reichardt, J.D. Furlow, and S.C. Bodine The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene Am J Physiol Endocrinol Metab 295 2008 E785 E797
169. J.C. Wang, M.K. Derynck, D.F. Nonaka, D.B. Khodabakhsh, C. Haqq, and K.R. Yamamoto Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes Proc Natl Acad Sci U S A 101 2004 15603 15608
170. X. Wang, L.D. Nelin, J.R. Kuhlman, X. Meng, S.E. Welty, and Y. Liu The role of MAP kinase phosphatase-1 in the protective mechanism of dexamethasone against endotoxemia Life Sci 83 2008 671 680
171. J.C. Webster, C.M. Jewell, J.E. Bodwell, A. Munck, M. Sar, and J.A. Cidlowski Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein J Biol Chem 272 1997 9287 9293
172. R.S. Weinstein Clinical practice. Glucocorticoid-induced bone disease N Engl J Med 365 2011 62 70
173. M.W. Whitehouse Anti-inflammatory glucocorticoid drugs: reflections after 60 years Inflammopharmacology 19 2011 1 19
174. M. Wiench, S. John, S. Baek, T.A. Johnson, M.H. Sung, T. Escobar, C.A. Simmons, K.H. Pearce, S.C. Biddie, P.J. Sabo, R.E. Thurman, J.A. Stamatoyannopoulos, and G.L. Hager DNA methylation status predicts cell type-specific enhancer activity EMBO J 30 2011 3028 3039
175. W. Wu, T. Pew, M. Zou, D. Pang, and S.D. Conzen Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival J Biol Chem 280 2005 4117 4124
176. S. Wust, D. Tischner, M. John, J.P. Tuckermann, C. Menzfeld, U.K. Hanisch, J. van den Brandt, F. Luhder, and H.M. Reichardt Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis PLoS One 4 2009 e8202
177. A. Yemelyanov, J. Czwornog, L. Gera, S. Joshi, R.T. Chatterton Jr., and I. Budunova Novel steroid receptor phyto-modulator compound A inhibits growth and survival of prostate cancer cells Cancer Res 68 2008 4763 4773
178. B. York, and B.W. O'Malley Steroid receptor coactivator (SRC) family: masters of systems biology J Biol Chem 285 2010 38743 38750
179. H. Yu, Y. Sun, C. Haycraft, V. Palanisamy, and K.L. Kirkwood MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1 Cytokine 56 2011 245 255